MENU
+Compare
ISPC
Stock ticker: NASDAQ
AS OF
Apr 24 closing price
Price
$1.22
Change
+$0.05 (+4.27%)
Capitalization
2.11M

ISPC iSpecimen Inc Forecast, Technical & Fundamental Analysis

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens... Show more

ISPC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ISPC with price predictions
Apr 23, 2025

Momentum Indicator for ISPC turns negative, indicating new downward trend

ISPC saw its Momentum Indicator move below the 0 level on April 22, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned negative. In of the 80 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ISPC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ISPC entered a downward trend on April 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ISPC's RSI Indicator exited the oversold zone, of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ISPC advanced for three days, in of 154 cases, the price rose further within the following month. The odds of a continued upward trend are .

ISPC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.230) is normal, around the industry mean (23.728). P/E Ratio (1.045) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.225) is also within normal values, averaging (41.794).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ISPC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ISPC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
ISPC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ISPC is expected to report earnings to fall 94.57% to -28 cents per share on October 31

iSpecimen Inc ISPC Stock Earnings Reports
Q3'24
Est.
$-0.29
Q4'24
Missed
by $5.03
Q2'24
Beat
by $0.09
Q1'24
Missed
by $0.10
Q4'23
Missed
by $0.10
The last earnings report on April 14 showed earnings per share of -534 cents, missing the estimate of -31 cents. With 23.51K shares outstanding, the current market capitalization sits at 2.11M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
450 Bedford Street
Phone
+1 781 301-6700
Employees
53
Web
https://www.ispecimen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AKAN1.180.06
+5.36%
Akanda Corp
ADSE13.430.66
+5.17%
Ads-Tec Energy PLC
PARR14.540.55
+3.93%
Par Pacific Holdings
STN88.101.50
+1.73%
Stantec
YI8.530.11
+1.31%
111 Inc

ISPC and Stocks

Correlation & Price change

A.I.dvisor tells us that ISPC and IART have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ISPC and IART's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ISPC
1D Price
Change %
ISPC100%
-2.68%
IART - ISPC
29%
Poorly correlated
+3.77%
STXS - ISPC
26%
Poorly correlated
-2.01%
RVTY - ISPC
26%
Poorly correlated
+1.46%
CTSO - ISPC
26%
Poorly correlated
-2.73%
RMD - ISPC
25%
Poorly correlated
+0.17%
More